|9:00 – 10:00 am||Networking Breakfast|| |
|9:30 – 10:00 am||Opening Program||Featuring:|
Kim Driscoll, Lieutenant Governor of Massachusetts
Medtech Impact Report Overview
Deepak Sahu, Managing Partner, Global MedTech, Alira Health
|10:00 – 10:45 am||Breakout 1||Topic: How Far We’ve Come|
|Breakout 1A||Women’s Health Diagnostics |
This session will discuss the evolution of women’s health diagnostics with an emphasis on improvements in diagnostic technology for multiple women’s health issues.
Marissa Fayer, CEO, DeepLook Medical
|Breakout 1B||Orthopedic Joint Replacement|
This session will look at how orthopedic joint replacements have evolved over time – from the diagnostic process to materials used in the medical devices, to how and where surgeries are performed, to rehabilitation.
Rajit Kamal, Experienced Medtech Executive
|Breakout 1C||Cardiac Intervention|
This session will examine how cardiac interventions have evolved over time to become more efficient, improve patient quality of life and outcomes.
Michelle Fox, Chief Medical Officer, Teleflex
|Breakout 1D||Diabetes Treatment |
This session will examine how life expectancy and quality of life for those with diabetes has changed over the last two decades. Attendees will learn how improvements in technology have benefited patients and caregivers alike.
Kenneth Snow, MD, Senior Director of Medical Affairs, Insulet
|10:45 – 11:00 am||Break|
|11:00 – 11:45 am||Breakout 2||Topic: Where Are We Now?|
|Breakout 2A||Women’s Health Diagnostics |
This session will examine the current standard of care for women’s health diagnostics with a focus on opportunities to improve access to care.
Sonal Patel, Vice President, Corporate Business Development and Strategy, Hologic
Manisha Shah-Bugaj, CEO, Activ Surgical
Elena Mendez-Escobar, PhD, Executive Director of Strategy and the Health Equity Accelerator, Boston Medical Center Health System
Craig Weiss, Senior Director, Diagnostics Commercial Operations, Hologic
|Breakout 2B||Orthopedic Joint Replacement|
This session will discuss the current standard of care for orthopedic joint replacements, including trends the industry is seeing and its impact on patients and caregivers.
Deepak Sahu, Managing Partner, Global MedTech, Alira Health
Michael S. Sherman, MD, MBA, MS, Venture Partner
RA Capital Management
Carl Vause, Chief Executive Officer and President, Hyalex Orthopedics
Jon Warner, MD, Chief, Shoulder Service and Chief Quality and Safety Officer, MGH Orthopedics
|Breakout 2C||Cardiac Intervention|
In this session, we’ll cover the current standard of care for cardiac interventions in order to gain a better understanding of how cardiac issues are treated, including gaps and opportunities.
Caroline Irungu, Global Commercial Strategy, Dassault Systems
Sanjeev Aggarwal, MD, MBA, Vice President, Global Clinical and Medical Affairs, Surgical Therapies, Abiomed
Kevin Croce, MD, PhD, Director of Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program, Brigham and Women’s Hospital
|Breakout 2D||Diabetes Treatment |
In this moderated discussion, a diabetes technology leader and clinician will discuss the current standard of care for diabetes treatment, interventions to prevent additional complications, and the impact of socio-economic factors on patients’ receiving care.
Rachel Robinson, Chief Operating Officer, MassMEDIC
Jon Bloom, MD, CEO, Podimetrics
Julien Dedier, MD, MPH, Boston Medical Center Health System
|11:45 am – 1:15 pm||Lunch & Panel||Breaking Down the Box: Leaders Who Are Moving Healthcare Forward|
In this panel discussion, we’ll hear from innovative medtech leaders who are not just thinking outside the box, but who are breaking down the box, changing the rules, and improving healthcare in the process. By hearing from strategic thinkers about big picture trends and future needs, we will be inspired to do better.
Rick Finch, Sr. Vice President, Consulting Services, Clarivate
Mike Ambrogi, Senior Technology Fellow, Novocure
Adam Sachs, CEO, Vicarious Surgical
Upma Sharma, PhD, CEO, Arsenal Medical
|1:15 – 2:00 pm||Breakout 3||Topic: Where Are We Going?|
|Breakout 3A||Women’s Health Diagnostics |
In this session, we’ll discuss what the next generation of women’s health diagnostic products could/should look like.
Erica Blight, PhD, Vice President Global Clinical Research, Client Services and Marketing, Sekisui Diagnostics
Alison Burkland, PhD, Co-Founder and CTO, Nanopath
Lana Caron, Sr. Director, Philips Ventures
|Breakout 3B||Orthopedic Joint Replacement|
In this session, we’ll discuss what the future of orthopedic joint replacements could/should look like.
Rob Olsen, Chief Commercial Officer, NextPhase Medical Devices
Mark Augusti, CEO, Conformis
James Brownhill, Sr. R&D Manager, Shoulder Reconstruction, DePuy Synthes
Lori Fontaine, VP of Global Clinical Strategy for Orthopedics, Sports Med & ENT, Smith + Nephew
|Breakout 3C||Cardiac Intervention|
In this session, we’ll discuss what the next generation of cardiac medical device products could/should look like.
Joe Mullings, CEO, The Mullings Group
Jeff Karp, PhD, Brigham and Women’s Hospital
Julie Pritchard-Hedtke, VP, Global Education and Medical Affairs, Siemens Healthineers Endovascular Robotics
Mark Turco, President and CEO, Cardiac Implants
|Breakout 3D||Diabetes Treatment |
In this session, we’ll discuss what the next generation of diabetes care products could/should look like.
Ravindra Sharma, Vice President, Product Management, Clarivate
Danielle Abramson, Ph.D., Global Head of IP Strategy & Branding, embecta
Jeff Valk, Co-Founder and CEO, Admetsys
|2:00 – 3:00 pm||Networking Reception|
|6:00 – 7:30 pm||Cocktail Reception|
|7:30 – 9:00 pm||Dinner & Program|
|Carlo W. Colesanti, President & Chief Executive Officer, NextPhase Medical Devices|
|David Kolstad, CEO, Gentuity|
Chair, MassMEDIC Board of Directors
|Brian Johnson, President, MassMEDIC|
|Rachel Robinson, Chief Operating Officer, MassMEDIC|
Chuck Alpuche, Retired Executive Vice President and Chief Operating Officer, Insulet
Thea James, MD, MPH, Vice President of Mission, Boston Medical Center Health System
|9:00 – 11:00 pm||Dessert Reception & Entertainment|